← Back to Search

Compass Course for Breast Cancer Survivors (CC-V Trial)

N/A
Waitlist Available
Led By Mary V Radomski, OTR/L, PhD
Research Sponsored by Mary Radomski
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion (about 4 months)
Awards & highlights

CC-V Trial Summary

This trial will test whether the Compass Course, a group intervention for individuals with breast cancer, is feasible and efficacious when delivered over Zoom.

Eligible Conditions
  • Breast Cancer

CC-V Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion (about 4 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion (about 4 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Engagement in Meaningful Activities survey
Change in Meaning in Life Questionnaire
Change in Purpose Status Question
+1 more
Secondary outcome measures
Change in Beck Depression Inventory -- II
Change in State-Trait Anxiety Inventory

CC-V Trial Design

1Treatment groups
Experimental Treatment
Group I: Compass CourseExperimental Treatment1 Intervention
Virtual Compass Course

Find a Location

Who is running the clinical trial?

Mary RadomskiLead Sponsor
2 Previous Clinical Trials
348 Total Patients Enrolled
1 Trials studying Breast Cancer
300 Patients Enrolled for Breast Cancer
Mary V Radomski, OTR/L, PhDPrincipal InvestigatorSenior Scientific Advisor
1 Previous Clinical Trials
48 Total Patients Enrolled

Media Library

Compass Course Clinical Trial Eligibility Overview. Trial Name: NCT04767464 — N/A
Breast Cancer Research Study Groups: Compass Course
Breast Cancer Clinical Trial 2023: Compass Course Highlights & Side Effects. Trial Name: NCT04767464 — N/A
Compass Course 2023 Treatment Timeline for Medical Study. Trial Name: NCT04767464 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for individuals to join this clinical experiment?

"According to the information on clinicaltrials.gov, this medical trial is not presently enrolling patients - despite having been first posted on March 1st 2021 and last modified on June 6th 2022. However, there are 2602 alternate studies actively recruiting new participants at this time."

Answered by AI
~5 spots leftby Mar 2025